3D-QSAR study of hallucinogenic phenylalkylamines by using CoMFA approach

The three-dimensional quantitative structure–activity relationship (3D-QSAR) has been studied on 90 hallucinogenic phenylalkylamines by the comparative molecular field analysis (CoMFA). Two conformations were compared during the modeling. Conformation I referred to the amino group close to ring position 6 and conformation II related to the amino group trans to the phenyl ring. Satisfactory results were obtained by using both conformations. There were still differences between the two models. The model based on conformation I got better statistical results than the one about conformation II. And this may suggest that conformation I be preponderant when the hallucinogenic phenylalkylamines interact with the receptor. To further confirm the predictive capability of the CoMFA model, 18 compounds with conformation I were randomly selected as a test set and the remaining ones as training set. The best CoMFA model based on the training set had a cross-validation coefficient q2 of 0.549 at five components and non cross-validation coefficient R2 of 0.835, the standard error of estimation was 0.219. The model showed good predictive ability in the external test with a coefficient Rpre2 of 0.611. The CoMFA coefficient contour maps suggested that both steric and electrostatic interactions play an important role. The contributions from the steric and electrostatic fields were 0.450 and 0.550, respectively.

[1]  Michael R. Braden,et al.  C-(4,5,6-trimethoxyindan-1-yl)methanamine: a mescaline analogue designed using a homology model of the 5-HT2A receptor. , 2006, Journal of medicinal chemistry.

[2]  Peter A. Kollman,et al.  PHOTOELECTRON SPECTRA OF PSYCHOTROPIC DRUGS. 6. RELATIONSHIPS BETWEEN PHYSICAL PROPERTIES AND PHARMACOLOGICAL ACTIONS OF AMPHETAMINE ANALOGS , 1982 .

[3]  Milica Mišić-Vuković,et al.  Investigation of electronic effects in the pyridine and pyridine N-oxide rings. Part 3. Reactions of substituted 2-carboxypyridine N-oxides with diazodiphenylmethane , 1979 .

[4]  Martin P Paulus,et al.  Effects of Hallucinogens on Locomotor and Investigatory Activity and Patterns: Influence of 5-HT2A and 5-HT2C Receptors , 1998, Neuropsychopharmacology.

[5]  James J. Chambers,et al.  A homology-based model of the human 5-HT2A receptor derived from an in silico activated G-protein coupled receptor , 2002, J. Comput. Aided Mol. Des..

[6]  P A Kollman,et al.  Photoelectron spectra of psychotropic drugs. 6. Relationships between the physical properties and pharmacological actions of amphetamine analogues. , 1981, Journal of medicinal chemistry.

[7]  D E Nichols,et al.  A novel (benzodifuranyl)aminoalkane with extremely potent activity at the 5-HT2A receptor. , 1998, Journal of medicinal chemistry.

[8]  B W Clare,et al.  Structure-activity correlations for psychotomimetics. 1. Phenylalkylamines: electronic, volume, and hydrophobicity parameters. , 1990, Journal of medicinal chemistry.

[9]  P Pauling,et al.  Anticholinergic substances: A single consistent conformation. , 1980, Proceedings of the National Academy of Sciences of the United States of America.

[10]  Angelo Vedani,et al.  Quasi‐atomistic Receptor Surrogates for the 5‐HT2A Receptor: A 3D‐QSAR Study on Hallucinogenic Substances , 1999 .

[11]  Minghu Song,et al.  Three-dimensional quantitative structure-activity relationship analyses of piperidine-based CCR5 receptor antagonists. , 2004, Bioorganic & medicinal chemistry.

[12]  G. Klebe,et al.  Molecular similarity indices in a comparative analysis (CoMSIA) of drug molecules to correlate and predict their biological activity. , 1994, Journal of medicinal chemistry.

[13]  R. Cramer,et al.  Comparative molecular field analysis (CoMFA). 1. Effect of shape on binding of steroids to carrier proteins. , 1988, Journal of the American Chemical Society.

[14]  Satya P. Gupta,et al.  QSAR studies on hallucinogens , 1983 .

[15]  Brian W. Clare,et al.  QSAR of benzene derivatives: comparison of classical descriptors, quantum theoretic parameters and flip regression, exemplified by phenylalkylamine hallucinogens , 2002, J. Comput. Aided Mol. Des..

[16]  D E Nichols,et al.  Structure-activity relationships of phenethylamine hallucinogens. , 1981, Journal of pharmaceutical sciences.

[17]  R. Glennon,et al.  Behavioral and serotonin receptor properties of 4-substituted derivatives of the hallucinogen 1-(2,5-dimethoxyphenyl)-2-aminopropane. , 1982, Journal of medicinal chemistry.

[18]  Olga Kennard,et al.  Crystal and molecular structure of the psychotropic drug 2-(4-ethyl-2,5-dimethoxyphenyl)-1-methylethylamine (4-ethyl-2,5-dimethoxyamphetamine) , 1974 .